Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christoph Schmidauer is active.

Publication


Featured researches published by Christoph Schmidauer.


Neurology | 2007

Recanalization after thrombolysis in stroke patients Predictors and prognostic implications

Alexandra Zangerle; Stefan Kiechl; M. Spiegel; M. Furtner; Michael Knoflach; Philipp Werner; A. Mair; G. Wille; Christoph Schmidauer; K. Gautsch; Thaddaeus Gotwald; S. Felber; Werner Poewe; Johann Willeit

Objective: To estimate rates, predictors, and prognostic importance of recanalization in an unselected series of patients with stroke treated with IV thrombolysis. Methods: We performed a CT angiography or transcranial Doppler (TCD) follow-up examination 24 hours after IV thrombolysis in 64 patients with documented occlusion of the intracranial internal carotid or middle cerebral artery (MCA). Complete recanalization was defined by a rating of 3 on the Thrombolysis in Myocardial Infarction or 4/5 on the Thrombolysis in Brain Ischemia grading scales. Information about risk factors, clinical features, and outcome was prospectively collected by standardized procedures. Results: Complete recanalization was achieved in 36 of the 64 patients (56.3%). There was a nonsignificant trend of recanalization rates to decline with a more proximal site of occlusion: 68.4% (M2 segment of MCA), 53.1% (M1 segment), and 46.2% (carotid T) (p for trend = 0.28). Frequencies of vessel reopening were markedly reduced in subjects with diabetes (9.1% vs 66.0% in nondiabetics, p < 0.001) and less so in subjects with additional extracranial carotid occlusion (p = 0.03). Finally, complete recanalization predicted a favorable stroke outcome at day 90 independently of the information provided by age, NIH Stroke Scale, and onset-to-needle time. Conclusions: We found a high rate of vessel recanalization after IV thrombolysis occlusion. However, recanalization was infrequent in patients with diabetes and extracranial carotid occlusion. Information on recanalization was a powerful, early predictor for clinical outcome.


Annals of Neurology | 2005

Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome

Christoph Schmidauer; Martin Sojer; Klaus Seppi; Heike Stockner; Birgit Högl; Birgit Biedermann; Elisabeth Brandauer; Cecilia Peralta; Gregor K. Wenning; Werner Poewe

In patients with Parkinsons disease, hyperechogenicity of the substantia nigra using transcranial ultrasound has been related to increased tissue concentrations of iron. Recently, deficient iron transport mechanisms in substantia nigra neurons have been described in postmortem tissue of patients with restless legs syndrome (RLS). This study was performed to study substantia nigra echogenicity in RLS patients compared with normal control subjects and Parkinsons disease patients. RLS patients had significantly reduced midbrain areas of hyperechogenicity compared with control subjects, and even more markedly reduced hyperechogenicity compared with Parkinsons disease patients. These findings lend further support to nigral iron deficiency as a pathogenetic factor in RLS. Ann Neurol 2005


Movement Disorders | 2007

Midbrain sonography in patients with essential tremor

Heike Stockner; Martin Sojer; Klaus Seppi K; Joerg Mueller; Gregor K. Wenning; Christoph Schmidauer; Werner Poewe

Several studies have reported an increased risk to develop Parkinsons disease (PD) in essential tremor (ET) populations. Hyperechogenicity of the substantia nigra (SN) is a common transcranial sonography (TCS) finding in PD and has been suggested as a PD risk‐marker in nonparkinsonian subjects. This study compared SN areas of 44 ET patients with 100 controls and 100 PD patients. Sixteen percent of ET patients had SN hyperechogenicity as compared with 3% of controls and 75% of PD patients. These findings might correspond to an increased risk of ET patients to develop PD. Long‐term follow‐up will show if those with hyperechogenic SN develop PD, while these without will not.


Neurology | 2012

Functional recovery after ischemic stroke—A matter of age Data from the Austrian Stroke Unit Registry

Michael Knoflach; Benjamin Matosevic; M. Rücker; M. Furtner; A. Mair; G. Wille; Alexandra Zangerle; Philipp Werner; Julia Ferrari; Christoph Schmidauer; Leonhard Seyfang; Stefan Kiechl; Johann Willeit

Objective: To analyze the association between patient age and good functional outcome after ischemic stroke with special focus on young patients who were numerically underrepresented in previous evaluations. Methods: Of 43,163 ischemic stroke patients prospectively enrolled in the Austrian Stroke Unit Registry, 6,084 (14.1%) were ≤55 years old. Functional outcome was available in a representative subsample of 14,256 patients free of prestroke disability, 2,223 of whom were 55 years or younger. Herein we analyzed the effects of age on good functional outcome 3 months after stroke (modified Rankin Scale score ≤2). Results: Good outcome was achieved in 88.2% (unadjusted probability) of young stroke patients (≤55 years). In multivariable analysis, age emerged as a significant predictor of outcome independent of stroke severity, etiology, performance of thrombolysis, sex, risk factors, and stroke complications. When the age stratum 56–65 years was used as a reference, odds ratios (95% confidence interval [95%CI]) of good outcome were 3.4 (1.9–6.4), 2.2 (1.6–3.2), and 1.5 (1.2–1.9) for patients aged 18–35, 36–45, and 46–55 years and 0.70 (0.60–0.81), 0.32 (0.28–0.37), and 0.18 (0.14–0.22) for those aged 66–75, 76–85, and >85 years (p < 0.001). In absolute terms, the regression-adjusted probability of good outcome was highest in the age group 18–35 years and gradually declined by 3.1%–4.2% per decade until age 75 with a steep drop thereafter. Findings applied equally to sexes and patients with and without IV thrombolysis or diabetes. Conclusions: Age emerged as a highly significant inverse predictor of good functional outcome after ischemic stroke independent of stroke severity, characteristics, and complications with the age-outcome association exhibiting a nonlinear scale and extending to young stroke patients. Neurology® 2012;78:279–285


Stroke | 2009

Cardiovascular Risk Factors and Atherosclerosis in Young Women Atherosclerosis Risk Factors in Female Youngsters (ARFY Study)

Michael Knoflach; Stefan Kiechl; Daniela Penz; Alexandra Zangerle; Christoph Schmidauer; Andrea Rossmann; Mahavir Shingh; Ralf Spallek; Andrea Griesmacher; David Bernhard; Peter Robatscher; Waltraud Buchberger; Walter Draxl; Johann Willeit; Georg Wick

Background and Purpose— Little research has been conducted into risk factors of atherosclerosis development in young women. Methods— This cross-sectional study enrolled 205 18- to 22-year-old female students from the Educational Centre for Allied Health Professions. A broad array of risk conditions and lifestyle behaviors was carefully assessed. Intima media thickness (IMT) was used as a well-established surrogate for atherosclerosis and a predictor of vascular risk. High IMT was defined as levels exceeding the 90th percentile in the common and/or internal carotid arteries. Results— In multivariable logistic regression analysis, systolic blood pressure, family history for hypertension, lipoprotein(a), homocysteine, T-cell immune reaction against human heat shock protein 60, and exposure to environmental tobacco smoke and exhaust gases emerged as independent predictors of high IMT. Obesity, metabolic syndrome, and classical risk factors other than high blood pressure were rare and unrelated to IMT. Findings were similar once focusing on IMT as a continuous variable. Conclusion— In female youngsters displaying initiating stages of vascular pathology, blood pressure level and numerous nontraditional risk conditions showed a significant relation to high IMT. Our study indicates that (auto)immune processes, high lipoprotein(a), and environmental exposure to tobacco smoke and traffic exhaust may play a role in early atherogenesis.


Sleep Medicine | 2009

Cerebral vasoreactivity decreases overnight in severe obstructive sleep apnea syndrome: A study of cerebral hemodynamics

Martin Furtner; Martin Staudacher; Birgit Frauscher; Elisabeth Brandauer; Maria M. Esnaola y Rojas; Viola Gschliesser; Werner Poewe; Christoph Schmidauer; Monika Ritsch-Marte; Birgit Högl

BACKGROUND OSAS has been associated with surrogate markers of atherosclerosis and is a known risk factor for stroke. However, there is limited data on the effects of recurring apneas in severe OSAS on cerebral circulation and their consequences on cerebrovascular reactivity and compliance. OBJECTIVE To evaluate cerebral blood flow velocity (CBFV) changes and vascular compliance in patients with severe obstructive sleep apnea syndrome (OSAS) using transcranial Doppler sonography (TCD) and cerebral pulse transit time (PTT). METHODS Seven patients (1 woman, 6 men, mean age 57.4 years) with severe OSAS underwent polysomnography at the sleep laboratory of the Neurology Department of Innsbruck Medical University. TCD was performed continuously during the whole night using a pulsed wave probe and was co-registered with routine polysomnography. Cerebrovascular reactivity was assessed by calculation of apnea and hypopnea-related CBFV changes. Arterial compliance was characterized by PTT derived from phase difference analysis between ECG and TCD signals. Sleep time was dichotomized into periods with high density of consecutive respiratory events (CRE) vs. periods with low density of consecutive respiratory events (non-CRE). TCD measurements of CBFV showed a regular, undulating pattern with flow minima immediately before apneas or hypopneas and maxima closely after their termination, reciprocally to peripheral O(2) saturation. CBFV reactivity was significantly diminished in CRE compared to non-CRE periods. PTT phase differences were reduced in non-CRE, and even more so in CRE periods, compared to initial wake phases. CONCLUSION We found severe disturbances of cerebrovascular reactivity in OSAS patients. Our data demonstrate loss of vasoreactivity and increase of arterial stiffness, indicated by CBF hyporeactivity and PTT reduction, especially during CRE periods. These changes are likely to impair cerebral circulation and may be detrimental to the endothelium.


Cerebrovascular Diseases | 2010

Basilar Artery Dissection: Series of 12 Consecutive Cases and Review of the Literature

M. Ruecker; Martin Furtner; Michael Knoflach; P. Werner; Thaddaeus Gotwald; Andreas Chemelli; Alexandra Zangerle; Barbara Prantl; Benjamin Matosevic; Christoph Schmidauer; Erich Schmutzhard; Johann Willeit; Stefan Kiechl

Background: Current knowledge on primary or isolated basilar artery dissection (IBAD) is limited to case vignettes and small patient series. Objective: To delineate the frequency and clinical presentations of IBAD along with short-term outcome, specific prognosis and targeted management. Methods: Data were derived from a series of 12 consecutive patients and a review of 88 cases reported in the literature. In all the cases, the dissection was confined to the basilar artery. Results: Disease incidence was estimated at 0.25 per 100,000 person-years. IBAD accounted for roughly 1.0% of all subarachnoid hemorrhage events and for no less than 10.5 and 4.5% of posterior circulation and brain-supplying artery dissections, respectively. The main clinical presentations were subarachnoid hemorrhage (46%) and posterior circulation brain ischemia (42%). Subarachnoid hemorrhage typically manifested at a higher age than brain ischemia (mean age, 48.9 vs. 41.4 years) and was more prevalent among women. Rebleedings related to pseudoaneurysm formation in patients with subarachnoid hemorrhage and recurrent ischemia in stroke patients were common in the acute phase (26.1 and 33.3%, respectively) but were rare in the long term. The outcome was generally favorable in stroke patients but variable in subarachnoid hemorrhage (case fatality rate, 21.7%). The mainstay of therapy for subarachnoid hemorrhage related to IBAD was endovascular occlusion of the aneurysm pouch whereas stroke patients were usually put on anticoagulants. Conclusions: IBAD is probably an underrecognized disease with heterogeneous clinical presentation and prognosis. It should be considered as a differential diagnosis in peritruncal subarachnoid hemorrhage, classic subarachnoid hemorrhage and posterior circulation stroke, especially in young individuals. Case management is challenging and has to be tailored to each patient.


Neurodegenerative Diseases | 2013

Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.

Philipp Mahlknecht; Klaus Seppi; Heike Stockner; Michael Nocker; Christoph Scherfler; Stefan Kiechl; Johann Willeit; Christoph Schmidauer; Arno Gasperi; Gregorio Rungger; Werner Poewe

Background: The clinical diagnosis of Parkinsons disease (PD) is currently anchored in its cardinal motor symptoms. According to hospital-based studies, an enlarged echogenicity in the area of the substantia nigra (SN) assessed with transcranial sonography (TCS) may represent a useful biomarker in the diagnosis of PD. Objective: To evaluate SN hyperechogenicity as a marker for PD in the Bruneck Study cohort, which is representative of the general elderly community. Methods: The diagnostic accuracy of TCS in distinguishing clinically diagnosed PD from nonparkinsonian subjects was assessed in 574 subjects from this cohort. Results: There was a good diagnostic accuracy of TCS in distinguishing PD subjects from nonparkinsonian subjects with an area under the curve value of 0.82. At a receiver-operating characteristic curve analysis-based cutoff value for SN hyperechogenicity of 0.18 cm2, TCS had a sensitivity of 88.2% (95% confidence interval, CI, 64.4-98.0), a specificity of 77.0% (95% CI 72.8-80.6), a positive predictive value of 12.7% (95% CI 7.8-20.0) and a negative predictive value of 99.4% (95% CI 97.8-100.0) for subjects with clinically definite PD at baseline. When analyzing the same population after 5 years with regard to the presence of known and newly diagnosed PD cases, baseline TCS yielded very similar diagnostic accuracy values. Conclusion: SN hyperechogenicity may represent a useful biomarker for PD not only in a hospital-based setting but also in the general community.


Neurology | 2001

Cerebral ergotism under treatment with ergotamine and ritonavir

M. Spiegel; Christoph Schmidauer; A. Kampfl; M. Sarcletti; Werner Poewe

A 37-year-old woman with AIDS was admitted to our stroke unit with an 18-hour history of acute-onset speech disorder and weakness of the right-sided extremities. She was taking regular antiviral medication, including the protease inhibitor ritonavir. One week before admission, she suddenly developed severe headache, nausea, and vomiting, but no photo- or phonophobia. Headaches were diffusely located, with alternating intensity in the following days. After receiving paracetamol, which did not improve the headache, her treating physician prescribed ergotamine suppositories. She had actually administered five of these suppositories over 4 consecutive days (corresponding to a cumulative dose of 10 mg). Ergotamines never were described before. Her headache eventually resolved on day 4, when antiviral therapy was discontinued. The patient had no vascular risk factors and no history of headache, but her sister had migraine headaches. Neurologic …


Neurology | 2012

Cerebral vasospasm following temporal lobe epilepsy surgery

Peter Lackner; Florian Koppelstaetter; P. Ploner; Martin Sojer; Judith Dobesberger; Gerald Walser; Erich Schmutzhard; Christoph Schmidauer; R. Bauer; Iris Unterberger; Martin Ortler; Eugen Trinka

Objective: Selective amygdalohippocampectomy (AHE) has been associated with postoperative cerebral vasospasm (CVS) in patients with medically intractable temporal lobe epilepsy. The incidence in temporal lobe resection (TLR) is unknown. This retrospective cohort study evaluates the incidence of and risk factors for the development of CVS in patients with TLR and AHE. Methods: A total of 119 patients were included between 1998 and 2009. All patients were evaluated by standardized preoperative and postoperative transcranial Doppler sonography (TCD) evaluations and neurologic examinations. Postoperative CT scans were evaluated by an independent radiologist and the volume of bleeding within the resection cavity was quantified. Results: Of 107 patients with longitudinal TCD data, 35 (32.7%) developed postoperative CVS. The incidence of CVS did not differ between patients with TLR and AHE. CVS was associated with female gender and a higher bleeding volume in the postoperative CT scan (p = 0.035 and 0.046). Patients with CVS showed a significantly higher incidence of postoperative neurologic signs and symptoms (48.6%) compared to patients without CVS (25%, p = 0.015). The mean length of stay was significantly prolonged in patients with diffuse CVS compared to patients with localized CVS or no CVS (28.8 ± 10.9, 24.2 ± 6.6, and 18.2 ± 6.1 days, p < 0.001). Conclusion: CVS is a frequent complication of surgery for temporal lobe epilepsy irrespective of the resection method. Important risk factors for the development of postoperative CVS are female gender and a higher amount of bleeding in the postoperative CT. Patients with CVS more frequently have neurologic signs and symptoms resulting in prolonged hospital stay.

Collaboration


Dive into the Christoph Schmidauer's collaboration.

Top Co-Authors

Avatar

Johann Willeit

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Stefan Kiechl

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Martin Sojer

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Michael Knoflach

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Alexandra Zangerle

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Benjamin Matosevic

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Martin Furtner

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Michael Spiegel

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barbara Prantl

Innsbruck Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge